GB1171619A - Vaccine adjuvants - Google Patents
Vaccine adjuvantsInfo
- Publication number
- GB1171619A GB1171619A GB1332266A GB1332266A GB1171619A GB 1171619 A GB1171619 A GB 1171619A GB 1332266 A GB1332266 A GB 1332266A GB 1332266 A GB1332266 A GB 1332266A GB 1171619 A GB1171619 A GB 1171619A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sulphonate
- phenoxyethyl
- nhr
- march
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/42—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1,171,619. Vaccines. WELLCOME FOUNDATION Ltd. 16 March, 1967 [25 March, 1966], No. 13322/66. Addition to 1,003,889. Heading A5B. [Also in Division C2] A vaccine comprises a non-pathogenic antigenic material (e.g. diptheria formol toxoid) and a novel adjuvant comprising an acid addition salt containing a cation of the formula: [CH 3 (CH 2 ) m -A-(CH 2 ) n -X-C(NHR<SP>2</SP>)NHR<SP>1</SP>]<SP>+</SP> or a corresponding free base, wherein R<SP>1</SP> is C 1-4 alkyl, R<SP>2</SP> is C 1-4 alkyl or 2-phenoxyethyl, X is S or NH, A is CH 2 or O, n is 2 or 3 and m is 11-15, provided that when A is CH 2 and X is NH, then R<SP>2</SP> is 2-phenoxyethyl. The anion in the acid addition salts may be Br- Cl-, I-, SO 4 2-, toluene-p-sulphonate, p-chlorobenzene-sulphonate, naphthalene-2-sulphonate, maleate or tatrate. An immunising set comprises preparations containing a non-pathogenic antigenic material and an adjuvant as defined above, which may be packed separately, to be used in combined form as a vaccine containing both.
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1332266A GB1171619A (en) | 1961-12-12 | 1966-03-25 | Vaccine adjuvants |
CH404967A CH544742A (en) | 1961-12-12 | 1967-03-21 | Guanidines and isothioureas adjuvants for diptheria and |
FR100002A FR92830E (en) | 1961-12-12 | 1967-03-23 | Preparation of new guanidines, iso-ureas and iso-thioureas endowed in particular with a biological activity. |
BE696102D BE696102A (en) | 1961-12-12 | 1967-03-24 | |
CA986208A CA921049A (en) | 1966-03-25 | 1967-03-25 | Guanidines and thioureas |
FR111445A FR6597M (en) | 1961-12-12 | 1967-06-22 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB44453/61A GB1003889A (en) | 1961-12-12 | 1961-12-12 | Guanidines and isothioureas |
GB1332266A GB1171619A (en) | 1961-12-12 | 1966-03-25 | Vaccine adjuvants |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1171619A true GB1171619A (en) | 1969-11-26 |
Family
ID=26249709
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1332266A Expired GB1171619A (en) | 1961-12-12 | 1966-03-25 | Vaccine adjuvants |
Country Status (4)
Country | Link |
---|---|
BE (1) | BE696102A (en) |
CH (1) | CH544742A (en) |
FR (2) | FR92830E (en) |
GB (1) | GB1171619A (en) |
-
1966
- 1966-03-25 GB GB1332266A patent/GB1171619A/en not_active Expired
-
1967
- 1967-03-21 CH CH404967A patent/CH544742A/en not_active IP Right Cessation
- 1967-03-23 FR FR100002A patent/FR92830E/en not_active Expired
- 1967-03-24 BE BE696102D patent/BE696102A/xx unknown
- 1967-06-22 FR FR111445A patent/FR6597M/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR92830E (en) | 1969-01-03 |
CH544742A (en) | 1974-01-15 |
BE696102A (en) | 1967-09-25 |
FR6597M (en) | 1969-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES409907A1 (en) | Imidazolyl-(2)-carbinols having hypolipidemic action and process for preparing them | |
PT86376A (en) | Process for the preparation of an adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide | |
ES465514A1 (en) | Glucosamine derivatives and a process for their manufacture | |
ES457050A1 (en) | Cyclic sulphonyloxyimides | |
GB1206491A (en) | PROCESS FOR PREPARING NITRO-p-PHENYLENEDIAMINES | |
ES439927A1 (en) | 7-Methoxy-6-thiatetracyclines and their preparation | |
GB1292803A (en) | Improvements relating to the production of antigens | |
ES436715A1 (en) | Herbicidal composition and method | |
BE750349A (en) | VACCINE FOR ACTIVE IMMUNIZATION CONTAINING AS ADJUSTING DIETHYLAMINOETHYLDEXTRANE | |
GB1171619A (en) | Vaccine adjuvants | |
GB1224591A (en) | Improvements in or relating to phosphonic acid anhydrides | |
GB1089767A (en) | Vaccine adjuvants | |
GB1213361A (en) | Quaternary ammonium compounds | |
BE834754R (en) | ADJUVANT AGENTS FORMED BY N-ACYL-MURAMIC ACID DERIVATIVES AND COMPOSITIONS OF VACCINES CONTAINING SUCH ADJUVANT AGENTS | |
ES262654A1 (en) | Immunising preparations containing clostridium perfringens toxins and toxoids | |
ES451555A1 (en) | Shampoo composition | |
ES393894A1 (en) | Piperidinemethyl ethers | |
GB1132287A (en) | Antibiotic compositions | |
GB1073521A (en) | Indole derivatives | |
GB794798A (en) | Pharmaceutical compositions | |
GB1077723A (en) | Preparation for the care of the skin | |
BE795155A (en) | QUATERNARY AMMONIUM COMPOUNDS FOR USE AS ADDITIVES IN DYEING | |
GB1378469A (en) | Phosphonic acid ester amides a process for their preparation and their use as nematicides | |
GB1067694A (en) | A process for the preparation of 2-alkyl-4-alkylamino-6-alkoxy-s-triazines | |
GB1238639A (en) |